New York, NY - (NewMediaWire) - February 26, 2019 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has completed the production of the initial inventory tranche of its CBD infused chewing gum (“CBD Gum”); branded as Tauri-Gum™. The manufacturer is waiting for the final printed sleeves and display trays, after which the product packaging can be completed. The physical blister packs have already arrived at the manufacturer and the Company can confirm that it will meet its previously stated timeline; the commercial launch will occur during March 2019. In other news, the Company continues to progress in its efforts to list its Tauri-Gum™ product on Amazon. The Company is focusing its efforts, over the next several days, on the completion of a legal confirmation letter to attest to the adherence of Tauri-Gum™ to the Federal rules and regulations that govern this space. Lastly the Company is working expeditiously to complete the construction of its E-Commerce site for the sale of Tauri-Gum™. As previously mentioned, this E-Commerce site is being built under the following URL address: (www.taurigum.com). ABOUT: TAURIGA SCIENCES, INC.Tauriga Sciences, Inc. (TAUG) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-GumTM. See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.In addition, the Company is currently constructing an E-Commerce site for the sale of its CBD Infused Chewing Gum. This site is being constructed under the following URL address: www.taurigum.comForward-Looking StatementsThis press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of ...

Phoenix, AZ - (NewMediaWire) - February 26, 2019 - For The Earth Corporation (the “Company” or “FTEG”) (OTCMKTS: FTEG) is excited to announce immediate plans for the establishment of a new state-of-the-art CBD extraction and production facility to be located in Eugene, OR. The facility will complement the Company’s already-established retail CBD footprint, which includes mall stores, mall kiosks, vending machines, and e-commerce storefronts, with physical locations in both Las Vegas and New York City.“We see For The Earth as an integrated CBD producer and retailer in the making,” stated Nelson Grist, CEO of FTEG. “In more mature industries, the value is in strategic partnerships and collaboration, but CBD is a frontier industry – as is anything related to cannabis right now. That means the lion’s share of the value lies in getting the best deals up the supply chain. There’s no better way to ensure the best possible pricing and dependability into the storefront than to buy from yourself.”Management notes that estimates for growth in the CBD space have been sharply boosted by the signing of the 2018 Farm Bill into law, with some research and analysis firms now anticipating well over $20 billion in total CBD sales in North America over the next 3 years, representing more than a 20-fold increase from current levels.“We have a lot of faith in the end-demand projections for this market because the vast majority of Americans haven’t discovered CBD yet,” continued Mr. Grist. “As more and more do, this market will suddenly seem vastly undersupplied, and we will have a direct route from extraction facility to end market consumer with no wildcards along the way. We love that positioning model and see a clear path to making it happen. We are getting started on the Eugene project and look forward to keeping our shareholders posted as it progresses.”About For The Earth CorporationFor The Earth Corporation is an emerging integrated CBD producer and retailer in the United States. The Company is in the process of establishing a vertical framework that will extend from cultivation to extraction and production to a strategic retail footprint that includes multiple locations in Las Vegas and New York featuring mall kiosks, vending machines, e-commerce, and full store locations serving both the human and pet CBD markets. Two mall leases have been signed recently in Las Vegas, with another vending machine location secured in New York City. The Company plans to expand its New York vending machine penetration by the end of 2019. In addition, the Company has begun early-stage work to establish a state-of-the-art CBD extraction and production facility in Eugene, OR.Forward-Looking StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See For The Earth’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or ...

Tarrytown, NY - (NewMediaWire) - February 26, 2019 - Nightfood, Inc. (OTCQB: NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced entry into the northern California market through a distribution relationship with the Wonder Ice Cream Company.Wonder is headquartered in Santa Clara, less than 10 miles north of San Jose, and about 45 miles south of San Francisco and Oakland. Wonder serves thousands of convenience stores, independent supermarkets, and specialty retailers across all of northern California, from Bakersfield to the Oregon border, and distributes brands such as Breyer’s, Ben & Jerry’s, Klondike, and Good Humor.Among the several thousand retail outlets Wonder services, there are approximately 300 upscale, high-volume, independent supermarkets which will be stocking Nightfood immediately, within the next four to eight weeks.“We’re thrilled to so quickly add a substantial presence in and around the San Francisco Bay Area,” commented Sean Folkson, CEO of Nightfood. “Over time, we expect the amount of business we do with Wonder to grow dramatically as some of the national accounts they currently service begin to carry Nightfood.”The highly anticipated national roll-out of Nightfood continues. The brand recently won 2019 Product of the Year in the ice cream category, in a survey of over 40,000 consumers conducted by Kantar Group.“The amount of media the Nightfood brand has received in recent weeks made this relationship very attractive for us,” stated Eric Capuchino, General Manager of Wonder. “We anticipate this product to be very much in demand among the clientele serviced by our upscale, independent supermarkets.”The Company has already shipped product to fulfill the initial Wonder purchase order, which was received on February 19. As of the date of this release, Nightfood revenues to date for the current quarter have surpassed the $102,188 reported for the quarter ending September 30, 2018, making this the highest revenue quarter in Company history. About Nightfood Holdings:Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc. On Feb 8, 2019, it was announced that Nightfood ice cream won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. With the overwhelming majority of at-home ice cream consumption occurring in the hours before bed, Nightfood’s sleep-friendly nighttime ice cream, formulated by sleep and nutrition experts, delivers benefits found in no other product on the market.Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond. Nightfood ice cream is rolling out nationally, and has recently announced distribution in the popular Meijer supermarket chain throughout the Midwest, with concentration in the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus, and Milwaukee.To enter the Nightfood® Ice Cream Giveaway, where the Company is giving away a one-year supply of Nightfood ice cream, plus a brand-new freezer to store it in, visit http://nightfoodicecream.com – each entrant gets a coupon for a free pint of ice cream (some purchase required).MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights. For more information, visit http://ir.Nightfood.com and http://Nightfood.comQuestions can be directed to investors@Nightfood.comForward Looking Statements: This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are ...

Los Angeles, CA - (NewMediaWire) - February 26, 2019 - NUGL Inc. (OTC: NUGL) (the “Company”), a one-stop shop for all things cannabis through the intelligent connection of consumers and companies, is pleased to announce the launch of its social media platform that includes features such as user profiles, real-time feeds and posts, direct messaging and more.“For the last few months we have quietly been developing a social media platform we like to refer to as ‘Software with no Limits,’” stated CJ Melone, Founder of NUGL. “We believe our social media platform performs better than any social media platform in or out of the industry and we allow all types of cannabis companies to use the software unlike other social media platforms. We build a fully integrated platform that we hope to not only help the cannabis industry thrive but compete in mainstream markets. We don’t see any reason why the cannabis industry, its business and its community need to be confined or limited in any way. We built this with the user in mind as well as full integration with our business profiles for anyone that likes cannabis and likes social media. Our platform provides real-time communication and is a major step in providing the industry with no limitations on the internet,” stated Melone. NUGL is now offering what they believe is a full solution on the NET combining social media, profiles with map search and NUGL Media’s ad server and magazines both in print and digital form. “When we launched our business profiles I really thought our development team outdid themselves. We kept getting community feedback from our user base asking why we didn’t offer user profiles with enhanced features. We also knew companies such as Facebook and Instagram did not support cannabis companies, so we thought, let’s just build the best social media platform there is. I think our team did just that,” stated Bob Waters, V.P. of sales. The Business Insider reports, “Social ad revenue in the U.S. will surpass $30 billion by 2021, according to new estimates from BI Intelligence, Business Insider's premium research service, based on historical data from IAB, PwC, and HIS; industry standard data collection companies. This figure is up from an estimated $15.5 billion in social ad revenue in 2016 and represents a five-year compound annual growth rate (CAGR) of 15%.”NUGL will be launching the new platform they call “limitless” to the market in early March and are confident not only will the platform stand on its own with companies like Facebook, but also complement all the other NUGL digital and print assets.About NUGLNUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.For more information and updates, visit one of the links below.Website: http://www.nugl.com/ Facebook: https://www.facebook.com/nuglapp/Instagram: https://www.instagram.com/nuglapp/Twitter: https://twitter.com/nuglapp/LinkedIn: https://www.linkedin.com/company/nuglapp/Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578Forward-Looking StatementsCertain statements in this press release may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating ...

Tulsa, OK - (NewMediaWire) - February 26, 2019 - Limitless Ventures Group, Inc. (OTC PINK: LVGI) announces today it is interviewing SEC Auditors to begin the process of becoming a fully reporting company, which moves LVGI one step closer to up-listing off the Pink Sheets. LVGI is simultaneously in discussions with a Brokerage firm to assist in fund-raising an initial amount of capital to cover this cost along with the costs of executing on our current business model of expanding in the Cannabis market, using alternative financing methods. Joseph Francella, CEO states, “This is one small step in the process but one large leap for LVGI and its shareholders.” LVGI is focused on making its wholly owned subsidiary, Summit Harbor Holdings, Inc. (SHHI) a fully diversified and vertically integrated Cannabis Company. SHHI President Devon Diaz and COO and Managing Director Matthew Habuda are reviewing current operations, seeking the next business opportunity and guiding SHHI and LVGI into the future in a big way.Through our process of locating a Brokerage firm that is willing to work with LVGI and fund us through alternative funding sources initially, LVGI has exceeded its original 30-day obligation to bring the agreed upon funds into the Company for THC². This deficiency has contractually caused THC²to notify us that we not in compliance and we now have a less than 30 business days to cure. Joseph Francella, CEO further states, “We are continually focused on bringing long term value into LVGI and creating a sustainable future for asset accumulation, revenue growth, profitability, and shareholder appreciation.” To that extent, LVGI is working with this Brokerage firm and in discussions with other alternative funding sources to capitalize all current and future projects.Forward-Looking Statements: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analysis and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of the release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.Joseph Francella 9186719935 joseph@lvginc.com

Tampa, FL - (NewMediaWire) - February 26, 2019 - B2Digital Incorporated (OTCMKTS: BTDG) announced today that the Colosseum Combat 48 LIVE Event held on Saturday February 23rd sold out and had the largest Colosseum Combat crowd to date.Colosseum Combat 48 had 9 amateur fights and 5 Professional fights for a total of 14 fights in front of the sold out crowd and the company recorded the highest revenue to date of any Colosseum Combat LIVE Event the company has held. The Event was broadcast LIVE online and through Social Media via PPV.B2Digital’s LIVE event technologies were in use and were used to digitally market and sell tickets online, through Social Media and the B2 Social Media Network. As in the last B2 Fighting Series Event, fans could purchase tickets directly on their iPhone, iPad or Android devices and pay for them with Apple Pay, Google Pay, Credit Cards or Cash and then show the electronic receipt at the door for entry into the event. Additionally, once inside the venue the fans could purchase Merchandise on their devices. All technologies deployed for the Event are part of the State of the Art B2 Marketing and Retail Digital technologies that were developed and are owned by the Company.“We have been working with the B2 Digital Group now for 18 months and we continue to grow our fan base and improve our relationships with our fighters and customers with the support that B2 Digital has supplied us in both knowledge and operations. This has been an excellent move for the Colosseum Combat organization and I am excited to continue working to develop and improve the B2 Fighting Series,” said, Mark Slater, CEO of Colosseum Combat.“We are rapidly rolling out our State of the Art Digital Technologies and our company is now running on a complete digital end to end technology and business system. The Colosseum Combat team embraced and operated the new Technologies flawlessly. We plan to deploy and effectively operate and improve our operations of our LIVE Events,” said, Greg P. Bell, Chairman as it takes its first steps towards reaching that objective with the goal of up listing to higher-level tiers of trading with OTC markets and working on becoming a full SEC Reporting Company. The company continues to be encouraged with the operational performance of its LIVE Event companies and Events, along with the large audience it has created with the B2 Social Media Network “B2SN” which surpassed 14 Million Social Media Connections to consumers in calendar year 2019. The Company continues to work on its strategy of Improving operations, acquiring additional Sports related companies and Growing the current B2 Digital business.The Company intends to release additional news and updates on a timely basis to its followers and shareholders. About B2Digital, IncorporatedWith extensive background in entertainment, television, video and technology, the Company is now forging ahead and becoming a full-service Live Event Sports Company. The Chairman and CEO of the company at the helm is Greg P. Bell. Capitalizing on the combination of his expertise, relationships and experience as well as his involvement with more than 40,000 LIVE events over his career for major sports leagues and entertainment venues, B2 Digital is in the process of developing and acquiring MMA and sports related companies to become a Premier Vertically Integrated LIVE Event Sports Company. B2's first strategy is to build an integrated Premier Development League for the MMA Mixed Martial Arts marketplace, which is a billion-dollar industry. B2 Digital will be creating and developing Development League champions that will move on to the MMA Major ...

MIRAMAR, FL - (NewMediaWire) - February 26, 2019 - Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team today February 26, at 11:00 AM Eastern time:Investors & persons of interest calling into event:Domestic US/Canada - 1-888-632-3385Direct Toll / International - 1-785-424-1673Conference ID - 85014The purpose of the call is to update investors on the previously announced and pending acquisitions that offer significant value to the Generex parent company. Joseph Moscato, Generex President & Chief Executive Officer, will discuss the company’s financing plans related to the acquisitions, as well as the strategic focus of Generex for 2019 and beyond. Topics for discussion include:Potential Acquisition of 13 Hospitals as well as Hospital IT and Management companyPotential Acquisition of World Class Nutraceutical CompanyPotential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patientsAcquisition of Direct to Patient End to End Pharmacy BusinessUpdate on Fuse Medical AcquisitionUpdate on Medisource Partners AcquisitionUpdate on Pantheon AcquisitionUpdate on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public StrategyAcquisition plans for NGIO Merger with Company with Synergistic PlatformsNGIO Acquisition of World Class IPDiscussion of financial and legal issueAbout Generex Biotechnology Corp.Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care.In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products.Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.Cautionary Note Regarding Forward-Looking StatementsThis release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on ...

Pismo Beach, CA - (NewMediaWire) - February 26, 2019 - CBD Expo Tour 2019 produced by MACE Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced today its key sponsors and the Official After Party for CBD Expo Tour MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.Key sponsors for CBD Expo Tour MIDWEST include CBD Lion as the Headline Sponsor, CBD Health & Wellness Magazine as the Gold Sponsor, Blue Moon Hemp as the Silver Sponsor, and the following are the Bronze Sponsors: Softgel Co., Botanica Testing, and Natural Life CBD. Branding sponsors include MOX as the Lanyard Sponsor, Leap Payments as the Badge Sponsor, 3CHI as the Swag Bag Sponsor, The Lebermuth Company as the After Party Sponsor, and Cannisence as the Press Room Sponsor.“We are very excited to have leaders in the cannabis industry supporting CBD Expo MIDWEST at varying levels of sponsorship,” said Celeste Miranda, Founder and CEO of CBD Expo Tour and MACE Media Group. “It is important to us that we partner with brands that align with our vision for the CBD Expo Tour and that want to educate consumers about the benefits of CBD.”The official CBD Expo MIDWEST After Party and award ceremony will take place on Friday, March 15th from 7 PM to 10 PM. The award ceremony will feature 10 awards for CBD products that will be judged. Categories include Best CBD Vape, Best CBD Capsule, Best CBD Tincture, Best Topical Relief, Best Cosmetic Skincare and more.“The CBD Expo Tour after parties are a great way for all of the participating exhibitors to network and build a community,” said Celeste. “After multiple days of hard work, it’s important to remember to have a good time and celebrate.”Those who are interested in attending CBD Expo MIDWEST or finding more information about the 2019 tour can visit www.cbdexpo.net.About CBD Expo TourCBD Expo Tour is the first of its kind to bring the largest CBD event platform and broadcast products with the community and share knowledge with the industry. The events feature more than 70 exhibitors, along with a substantial lineup of speaker presentations and panel discussions from experts in the research, production, globalization, and sale of CBD products. The themes for CBD Expo MIDWEST are CBD 101, CBD Tools & Applications, Medical Advancements, and Industry Trends. CBD Expo Tour 2019 will be held in Indiana, Washington, Colorado, California, and Florida. Find out more at CBD Expo Tour or connect on social media: Facebook, Instagram, Twitter.About MACE Media GroupMACE Media Group publishes niched cannabis industry trade publications. Its first title, Terpenes and Testing Magazine, was the first industry trade publication devoted to cannabis science. Its newest publication, CBD Health & Wellness Magazine, revolves around the growing CBD industry to provide news on trending applications, medical research, and updates with laws and regulations. MACE also produces many trade events that attract dozens of cannabis and mainstream media journalists. Currently, MACE Media Group is producing a tour of CBD expos bringing together thousands of industry influencers, forming the most comprehensive CBD event in the United States. Find out more at www.MACEMediaGroup.comPublic Relations Contact: Kathleen Gonzales CMW Media (619) 368-2701

ANAHEIM, CA - (NewMediaWire) - February 26, 2019 - BioCorRx Inc. (OTCQB: BICX) (“Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that it has engaged IRISYS, LLC, a contract pharmaceutical product development and manufacturing services company, for the development and manufacturing of BICX102, a multi-month sustained release naltrexone implant. The Company plans to conduct clinical trials and seek FDA approval for BICX102 as a treatment for opioid and alcohol use disorders.“We look forward to partnering with such a reputable partner as IRISYS to manufacture our naltrexone implant,” said Brady Granier, CEO and President of BioCorRx, Inc. “Having received the National Institute on Drug Abuse grant award last month and following a pre-IND meeting we had with the FDA last year, we are now in a position to begin the manufacturing and development process for our lead pharmaceutical candidate, BICX102. IRISYS brings valuable experience beyond manufacturing that should also contribute to our success as we move forward through the clinical and regulatory process for BICX102.”IRISYS was founded in 1996 to provide contract pharmaceutical product development and manufacturing services, specializing in formulation development, cGMP manufacturing of clinical trial materials and commercial pharmaceutical products, as well as strategic consulting related to the drug development process. IRISYS’ custom approach to drug development is supported by its scientific and regulatory experience in moving more than a hundred drug products from discovery to clinical development and commercialization. For more information about IRISYS, visit www.irisys.com. “IRISYS is pleased to contribute its expertise to the development of BICX102, which promises to be a significant factor in addiction recovery and we believe it will aid in the effort to combat the national opioid crisis,” stated Robert Giannini, Ph.D., CSO/CTO of IRISYS.According to the National Institute of Drug Abuse, more than 130 people in the United States die every day of an opioid overdose and the White House declared it a national Public Health Emergency on Oct. 26, 2017. The abuse and misuse of opioids has fostered a $1.4 billion opioid addiction treatment industry in the U.S., as of 2014, according to the Addiction Treatment Advisory Group's (ATAG) report.About BioCorRxBioCorRx Inc. (OTCQB: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids, and can prevent opioid overdose following relapse. The second component of the program developed by BioCorRx Inc. is a Cognitive Behavioral Therapy (CBT) program tailored specifically for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The Company also conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals. For more information on BICX and product pipeline, visit www.BioCorRx.com.Twitter: @BioCorRxIncLinkedIn: https://www.linkedin.com/company/biocorrx-inc/Facebook: @BioCorRxInstagram: @biocorrx_incSafe Harbor StatementThe information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking ...

VAUGHAN, ONTARIO - (NewMediaWire) - February 26, 2019 - Comepay, Inc. (OTCPINK: CMPY) (“the Company”) is pleased to announce that its wholly owned subsidiary Chek-Online LLC, a leading manufacturer of fiscal cash registers in Russia, and developer of the family of Cassatka smart terminals, has again added increased functionality to its smart terminals by integrating merchant acquiring services from two large banks in Russia for its versatile handheld Cassatka-Mini terminal. Merchant acquiring services are services provided by the acquiring bank allowing users access to card networks (credit, debt and prepaid cards) enabling users to process payments and other transactions online.Chek-online plans to expand to several additional partner banks for trade acquiring for its Cassatka-Mini Smart terminal, however, the integration process has already been launched with two large banks based in Russia, VTB Bank and Otkritie FC Bank.VTB Bank and its financial group are one of the leading banks in Russia offering a wide range of banking services and products in Russia, CIS, Europe, Asia, Africa, and the U.S. [1] Otkritie FC Bank is one of the principal full-service banks in Russia and was the largest privately-owned bank in Russia before it came under the control of the Central Bank of the Russian Federation. Otkritie FC Bank currently has over 30,000 corporate clients and 165,000 small business clients. [2]Felix Naff, the President of Comepay Inc., commented, “With financial institutions making high demands on functionality, reliability and manufacturability of cash registers, this cooperation by each of VTB and Otkritie banks with Chek-Online to integrate merchant acquiring services in the Cassatka-Mini is a testament to the product’s superior design and utility. The Cassatka-Mini has proven to be a very dependable terminal for processing payments.”Under the compliance requirements of Russian taxation legislation, 54-FZ which requires businesses and individuals to now use federally compliant cash registers, including a fiscal chip for processing sales transactions, the terminal must successfully, and with limited errors, process payment transactions for Visa, MasterCard and MIR, as well as mobile payment options including Apple Pay and Google Pay.The Company expects that the Integration of the merchant acquiring under our partnership with VTB and Otkritie banks for the handheld Cassatka-Mini will enable Chek-Online to expand its customer network more rapidly with this product line, and to also attract additional partner banking relationships for our family of smart terminals.[1] https://en.wikipedia.org/wiki/VTB_Bank[2] https://sputniknews.com/russia/201708311056974076-otkritie-bank-outflowAbout ComepayThe Comepay group of companies including Comepay, RP Systems, M-NN LLC and Chek-Online have been operating for over 11 years providing internet acquiring services and support, facilitating instant payments and internet-based payment transactions via kiosks, mobile interfaces and web-based applications such as electronic wallets. The Company also leases and sells cash registers and Point of Sale (POS) systems, including its recently developed proprietary multifunctional smart POS fiscal cash register system. Combining proprietary software and equipment, Comepay processes over 10 million customer payments per month and presently has more than 10,000 kiosks across Russia. The companies are currently focusing their planned business expansion on their family of smart POS fiscal cash register systems called “Cassatka” in order to help businesses comply with newly released Russian taxation legislation, 54-FZ which requires a further 3 million businesses in fiscal 2019 to install new, federally compliant on-line cash registers. The Cassatka, Comepay’s family of multifunctional smart POS online fiscal cash registers can process payments and meet fiscal data storage requirements for participating businesses, including web-based businesses. The product line is convenient and a cost competitive solution for businesses to meet the ...